CannTrust Launches Three New Medical Cannabis Product Formulations

CannTrust Holdings Inc. (((&quot, CannTrust&quot, or the &quot, Company&quot, , TSX:TRST, NYSE:CTST) is pleased to announce that it has launched three new cannabis extract formulations to meet the growing demand for oil-based products. The new formulations are designed to fill previously unmet needs within the Canadian medical market, identified through market research and the Company's long-standing relationships with thousands of medical cannabis patients and their healthcare practitioners.
CannTrust's three new product formulations are:

1. High Dose CBD Capsules (25mg/capsule) – the highest dose CBD capsules currently available in Canada;

 

2. High Dose CBD Drops (50mg/mL); and

 

3. Low Dose 1:1 Capsules (2.5mg CBD: 2.5mg THC).